Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-038562)

Filing Details

Accession Number:: 0001209191-17-038562
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-08 16:40:58
Reporting Period:: 2017-06-06

Filing Date:: 2017-06-08
Accepted Time:: 2017-06-08 16:40:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610618	Cidara Therapeutics Inc.	CDTX	Biological Products, (No Disgnostic Substances) (2836)	461537286

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1702287	Taylor Sandison	6310 Nancy Ridge Dr, Suite 101 San Diego CA 92121	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-06	656	$5.90	6,351	No	4	P	Direct
Common Stock	Acquisiton	2017-06-07	19,344	$5.90	25,695	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 2,841 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 19, 2017.